Servier lance une Offre Publique d’Achat amicale sur 49% du capital d’Egis Pharmaceuticals PFC

Press release (01 October 2013):

Press release (24 September 2013):

Invitation to Investors

OPERATION PLAN and BUSINESS REPORT regarding ARTS ET TECHNIQUES DU PROGRES' voluntary public purchase Offer for all registered ordinary voting shares issued by EGIS PHARMACEUTICALS PUBLIC LIMITED COMPANY and currently not owned by ARTS ET TECHNIQUES DU PROGRES. (Updated 27 September 2013)

VOLUNTARY PUBLIC PURCHASE OFFER OF ARTS ET TECHNIQUES DU PROGRES AS OFFEROR FOR ALL REGISTERED ORDINARY VOTING SHARES OF EGIS PHARMACEUTICALS PUBLIC LIMITED COMPANY. (Updated 27 September 2013)

Interview: Pascal Touchon, Head of Business Development & Scientific Cooperation at Servier. (24 September 2013)